Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Alvarez

Showing results (361-370 of 382) with videos related to

Pageof 39
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 3, 2025
Contact Aspiration Alone or Combined With Stent Retriever Thrombectomy for Middle Cerebral Artery Large Vessel OcclusionPedro Navia, Andres Fernandez-Prieto, Alberto Alvarez-Muelas, et al.
Cancer|April 13, 2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Alvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, et al.
British Journal of Haematology|September 12, 2022
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, et al.
Annals of Hematology|December 7, 2023
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomesTiziano Barbui, Alessandra Carobbio, Valerio De Stefano, et al.
Blood Cancer Journal|February 10, 2021
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practiceValentín Garcia-Gutiérrez, Alejandro Luna, Juan M Alonso-Dominguez, et al.
Journal of Neurointerventional Surgery|November 20, 2024
Burden of incidental cerebral aneurysms on lifestyle and quality of life: a survey of patients in expectant management (the SPICE Study)Jorge Rodríguez-Pardo, Jesús García-Castro, Carlos Gómez-Escalonilla, et al.
Leukemia|May 31, 2019
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control studyTiziano Barbui, Arianna Ghirardi, Arianna Masciulli, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
American Journal of Hematology|December 10, 2019
Second cancers in MPN: Survival analysis from an international studyMonia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Pageof 39

Showing results (361-370 of 382) with videos related to

Sort By:
Pageof 39
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 3, 2025
Contact Aspiration Alone or Combined With Stent Retriever Thrombectomy for Middle Cerebral Artery Large Vessel OcclusionPedro Navia, Andres Fernandez-Prieto, Alberto Alvarez-Muelas, et al.
Cancer|April 13, 2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Alvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, et al.
British Journal of Haematology|September 12, 2022
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, et al.
Annals of Hematology|December 7, 2023
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomesTiziano Barbui, Alessandra Carobbio, Valerio De Stefano, et al.
Blood Cancer Journal|February 10, 2021
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practiceValentín Garcia-Gutiérrez, Alejandro Luna, Juan M Alonso-Dominguez, et al.
Journal of Neurointerventional Surgery|November 20, 2024
Burden of incidental cerebral aneurysms on lifestyle and quality of life: a survey of patients in expectant management (the SPICE Study)Jorge Rodríguez-Pardo, Jesús García-Castro, Carlos Gómez-Escalonilla, et al.
Leukemia|May 31, 2019
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control studyTiziano Barbui, Arianna Ghirardi, Arianna Masciulli, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
American Journal of Hematology|December 10, 2019
Second cancers in MPN: Survival analysis from an international studyMonia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Pageof 39